These conflicting activities may be related to the duration and the importance of IFN-γ signaling which are affected by tumor burden, immune cell infiltration characteristics, and cancer treatment (immunotherapies and chemotherapies) [36]. The gene discussed is IFNG; the disease is neoplasm.